Dr Eisfeld on Timing of Molecular Testing and the Start of T

Ann-Kathrin Eisfeld, MD, discusses factors to consider when deciding whether to start treatment right away or wait for molecular testing results in patients with acute myeloid leukemia.

Related Keywords

Ann Kathrin Eisfeld , , Leukemia Outcomes Research , Clarad Bloomfield Center , Ohio State University Comprehensive Cancer Center , Division Of Hematology , Leukemia Research Program , Key Updates In The Management Of Acute Myeloid Leukemia And Their Application Clinical Practice , Onclive Tv ,